The efficacy and safety of adding hepatic arterial infusion chemotherapy using cisplatin to lenvatinib for advanced hepatocellular carcinoma
Adding HAIC using cisplatin to lenvatinib improved the response to treatment and outcome for advanced HCC patients. Further studies are needed to confirm these results and explore the clinical positioning of lenvatinib plus HAIC.
Authors
- Akihiro Seki (ORCID: https://orcid.org/0000-0002-0356-1810)
- Masao Honda (ORCID: https://orcid.org/0000-0003-3050-5854)
- Hidetoshi Nakagawa (ORCID: https://orcid.org/0000-0002-3657-7405)
- Noboru Takata (ORCID: https://orcid.org/0000-0002-5890-4083)
- Tomoyuki Hayashi (ORCID: https://orcid.org/0000-0002-4416-2912)
- Hajime Takatori (ORCID: https://orcid.org/0000-0002-6680-2925)
- Kouki Nio (ORCID: https://orcid.org/0000-0002-0971-8313)
- Eishiro Mizukoshi (ORCID: https://orcid.org/0000-0002-2036-9599)
- Taro Yamashita (ORCID: https://orcid.org/0000-0002-3383-9131)
- Takeshi Terashima (ORCID: https://orcid.org/0000-0002-1052-0101)
- Noriho Iida (ORCID: https://orcid.org/0000-0002-2917-5053)
- Makoto Yamamoto (ORCID: https://orcid.org/0000-0001-7844-331X)
- Tetsuro Shimakami (ORCID: https://orcid.org/0000-0002-8308-4056)
- Tadashi Toyama (ORCID: https://orcid.org/0000-0003-0162-6286)
- Hidenori Kido (ORCID: https://orcid.org/0000-0002-8579-2507)
- Shinya Yamada (ORCID: https://orcid.org/0000-0001-5726-3926)
Institutions
- University of Fukui (JP)
- Kanazawa Medical University (JP)
- Kanazawa University Hospital (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1111/hepr.14194
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64